Wafik S. El-Deiry, MD, PhD, FACP
@weldeiry.bsky.social
Physician-Scientist Oncologist, Director Legorreta Cancer Center, Associate Dean, past Faculty Exec Cmte member, Brown Univ, ACS Professor, Chair, WIN Consortium in Precision Oncology, Entrepreneur, Boat Captain, joined Nov 16 ‘24 Pubs: tinyurl.com/s98xg3u
Pinned
I’m here at @BrownUniversity Family Weekend on the College Green to speak with you about exciting developments at the #LegorretaCancerCenter over the last few years. As a colon cancer doctor my messa...
TikTok video by weldeiry
www.tiktok.com
On 10-26-2024 I was at Brown University Family Weekend on College Green to share exciting progress at #LegorretaCancerCenter.
As a colon cancer doctor my message was to make sure you get your screening colonoscopy to prevent colon cancer as this could save your life.
www.tiktok.com/t/ZTYLaQo9J/
As a colon cancer doctor my message was to make sure you get your screening colonoscopy to prevent colon cancer as this could save your life.
www.tiktok.com/t/ZTYLaQo9J/
Snowy morning in Providence at start of business travel.
January 18, 2026 at 1:05 PM
Snowy morning in Providence at start of business travel.
Limit on multiyear funding of NIH grants is a sticking point in Senate budget talks
www.statnews.com/2026/01/16/n...
www.statnews.com/2026/01/16/n...
Limit on multiyear funding of NIH grants is a sticking point in Senate budget talks
A clause limiting the use of multiyear NIH grant funding has become a sticking point as the Senate appropriations panel finalizes the HHS spending bill.
www.statnews.com
January 17, 2026 at 4:57 PM
Limit on multiyear funding of NIH grants is a sticking point in Senate budget talks
www.statnews.com/2026/01/16/n...
www.statnews.com/2026/01/16/n...
Covid Infection, Covid Vaccines and Cancer youtu.be/lsttzNuefhY via @YouTube
Vaccins COVID et Cancer l'étude explosive censurée par une cyberattaque mystérieuse
YouTube video by France-Soir
youtu.be
January 17, 2026 at 12:11 AM
Covid Infection, Covid Vaccines and Cancer youtu.be/lsttzNuefhY via @YouTube
Happy Friday from the Ocean State’s Legorreta Cancer Center at Brown University.
There is much progress and momentum in the fight against cancer in Rhode Island.
2026 is shaping up as a great year at Brown’s superb academic environment. @BrownUCancer @BrownMedicine @BrownUniversity
There is much progress and momentum in the fight against cancer in Rhode Island.
2026 is shaping up as a great year at Brown’s superb academic environment. @BrownUCancer @BrownMedicine @BrownUniversity
January 16, 2026 at 2:04 PM
Happy Friday from the Ocean State’s Legorreta Cancer Center at Brown University.
There is much progress and momentum in the fight against cancer in Rhode Island.
2026 is shaping up as a great year at Brown’s superb academic environment. @BrownUCancer @BrownMedicine @BrownUniversity
There is much progress and momentum in the fight against cancer in Rhode Island.
2026 is shaping up as a great year at Brown’s superb academic environment. @BrownUCancer @BrownMedicine @BrownUniversity
This hospice has a bold new mission: saving lives
A hospice in Uganda asked itself: Can we do more than ease the pain of dying? Can we actually prevent deaths from cervical and breast cancer?
www.npr.org/2026/01/16/g...
A hospice in Uganda asked itself: Can we do more than ease the pain of dying? Can we actually prevent deaths from cervical and breast cancer?
www.npr.org/2026/01/16/g...
This hospice has a bold new mission: saving lives
A hospice in Uganda asked itself: Can we do more than ease the pain of dying? Can we actually prevent deaths from cervical and breast cancer?
www.npr.org
January 16, 2026 at 12:59 PM
This hospice has a bold new mission: saving lives
A hospice in Uganda asked itself: Can we do more than ease the pain of dying? Can we actually prevent deaths from cervical and breast cancer?
www.npr.org/2026/01/16/g...
A hospice in Uganda asked itself: Can we do more than ease the pain of dying? Can we actually prevent deaths from cervical and breast cancer?
www.npr.org/2026/01/16/g...
Some reassuring data at the population level in France👇
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France
jamanetwork.com/journals/jam...
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France
jamanetwork.com/journals/jam...
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults in France
This cohort study uses the data from all adults aged 18 to 59 years living in France on November 1, 2021, to evaluate whether there is an association of receipt of an mRNA COVID-19 vaccine with long-t...
jamanetwork.com
January 16, 2026 at 5:54 AM
Some reassuring data at the population level in France👇
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France
jamanetwork.com/journals/jam...
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France
jamanetwork.com/journals/jam...
Reposted by Wafik S. El-Deiry, MD, PhD, FACP
Physical Activity and QoL Lessons from ASCO GI26 - Wafik S. El-Deiry
@weldeiry.bsky.social
oncodaily.com/voices/wafik...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
@weldeiry.bsky.social
oncodaily.com/voices/wafik...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Wafik S. El-Deiry: Physical Activity and QoL Lessons from ASCO GI26 - OncoDaily
Wafik S. El-Deiry: Physical Activity and QoL Lessons from ASCO GI26 / ASCO GI2026, ASCO GI26, cancer, OncoDaily, Oncology, Wafik S. El-Deiry
oncodaily.com
January 15, 2026 at 3:42 PM
Physical Activity and QoL Lessons from ASCO GI26 - Wafik S. El-Deiry
@weldeiry.bsky.social
oncodaily.com/voices/wafik...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
@weldeiry.bsky.social
oncodaily.com/voices/wafik...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Some nice ideas👇
What business school taught me about running a research lab
www.science.org/content/arti...
What business school taught me about running a research lab
www.science.org/content/arti...
What business school taught me about running a research lab
Not everyone can do an MBA—but principal investigators should seek out opportunities to become better leaders, this professor writes
www.science.org
January 15, 2026 at 8:57 AM
Some nice ideas👇
What business school taught me about running a research lab
www.science.org/content/arti...
What business school taught me about running a research lab
www.science.org/content/arti...
Many US scientists have reported a rise in targeted harassment. Here are tools and tips to safeguard your cybersecurity.
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Client Challenge
www.nature.com
January 15, 2026 at 8:46 AM
Many US scientists have reported a rise in targeted harassment. Here are tools and tips to safeguard your cybersecurity.
www.nature.com/articles/d41...
www.nature.com/articles/d41...
70 Percent of Cancer Patients Now Survive at Least Five Years, Study Finds
Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, physicians warn
www.scientificamerican.com/article/70-p...
Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, physicians warn
www.scientificamerican.com/article/70-p...
Cancer Survival Rates Are the Highest They’ve Been since the 1970s
Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, physicians warn
www.scientificamerican.com
January 14, 2026 at 11:58 PM
70 Percent of Cancer Patients Now Survive at Least Five Years, Study Finds
Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, physicians warn
www.scientificamerican.com/article/70-p...
Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, physicians warn
www.scientificamerican.com/article/70-p...
Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study
www.news-medical.net/news/2026011...
www.news-medical.net/news/2026011...
Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Swed...
www.news-medical.net
January 14, 2026 at 11:56 PM
Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study
www.news-medical.net/news/2026011...
www.news-medical.net/news/2026011...
Simmons Cancer Center earns exceptional rating in its renewal as an NCI-designated Comprehensive Cancer Center
www.newswise.com/articles/sim...
www.newswise.com/articles/sim...
Simmons Cancer Center earns exceptional rating in its renewal as an NCI-designated Comprehensive Cancer Center | Newswise
The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern earned an exemplary merit score from the Center from Scientific Review as part of the renewal of its comprehensive designation by t...
www.newswise.com
January 14, 2026 at 11:54 PM
Simmons Cancer Center earns exceptional rating in its renewal as an NCI-designated Comprehensive Cancer Center
www.newswise.com/articles/sim...
www.newswise.com/articles/sim...
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
www.news-medical.net/news/2026011...
www.news-medical.net/news/2026011...
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer wi...
www.news-medical.net
January 14, 2026 at 11:51 PM
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
www.news-medical.net/news/2026011...
www.news-medical.net/news/2026011...
ctDNA Negativity in Rectal Cancer Signals “Clear Stop” to Adjuvant Chemo
www.cancernetwork.com/view/ctdna-n...
www.cancernetwork.com/view/ctdna-n...
ctDNA Negativity in Rectal Cancer Signals “Clear Stop” to Adjuvant Chemo | CancerNetwork
Data from the GALAXY study in Japan may inform future use of total neoadjuvant therapy among patients with rectal cancer in the US.
www.cancernetwork.com
January 14, 2026 at 11:47 PM
ctDNA Negativity in Rectal Cancer Signals “Clear Stop” to Adjuvant Chemo
www.cancernetwork.com/view/ctdna-n...
www.cancernetwork.com/view/ctdna-n...
Customized N-of-1 Cancer Therapies Could Improve Outcomes
www.insideprecisionmedicine.com/topics/oncol...
www.insideprecisionmedicine.com/topics/oncol...
Customized N-of-1 Cancer Therapies Could Improve Outcomes
Personalized cancer drug combinations, prescribed according to tumor molecular characteristics, could improve outcomes without impacting safety.
www.insideprecisionmedicine.com
January 14, 2026 at 11:44 PM
Customized N-of-1 Cancer Therapies Could Improve Outcomes
www.insideprecisionmedicine.com/topics/oncol...
www.insideprecisionmedicine.com/topics/oncol...
Some good news👇
US hits new milestone in cancer survival rates. See the results.
www.usatoday.com/story/life/h...
US hits new milestone in cancer survival rates. See the results.
www.usatoday.com/story/life/h...
US hits new milestone in cancer survival rates. See the results.
The annual report from the American Cancer Society shared good news about the fight against the disease.
www.usatoday.com
January 14, 2026 at 11:41 PM
Some good news👇
US hits new milestone in cancer survival rates. See the results.
www.usatoday.com/story/life/h...
US hits new milestone in cancer survival rates. See the results.
www.usatoday.com/story/life/h...
Lots of progress at Danoff Life Sciences Research Building in Providence’s Jewelry District @BrownMedicine
#LegorretaCancerCenter @BrownUCancer @BrownUnivHealth
#LegorretaCancerCenter @BrownUCancer @BrownUnivHealth
January 14, 2026 at 1:48 PM
Lots of progress at Danoff Life Sciences Research Building in Providence’s Jewelry District @BrownMedicine
#LegorretaCancerCenter @BrownUCancer @BrownUnivHealth
#LegorretaCancerCenter @BrownUCancer @BrownUnivHealth
A $2,500 full body MRI scan said he was healthy. Then he had a catastrophic stroke.
Prenuvo promotes full body MRI scans to detect hazardous conditions early. But medical associations say they may cause unnecessary alarm or a false sense of security.
www.washingtonpost.com/health/2026/...
Prenuvo promotes full body MRI scans to detect hazardous conditions early. But medical associations say they may cause unnecessary alarm or a false sense of security.
www.washingtonpost.com/health/2026/...
A $2,500 full body scan said he was healthy. Then he had a catastrophic stroke.
Prenuvo promotes full body MRI scans to detect hazardous conditions early. But medical associations say they may cause unnecessary alarm or a false sense of security.
www.washingtonpost.com
January 14, 2026 at 3:57 AM
A $2,500 full body MRI scan said he was healthy. Then he had a catastrophic stroke.
Prenuvo promotes full body MRI scans to detect hazardous conditions early. But medical associations say they may cause unnecessary alarm or a false sense of security.
www.washingtonpost.com/health/2026/...
Prenuvo promotes full body MRI scans to detect hazardous conditions early. But medical associations say they may cause unnecessary alarm or a false sense of security.
www.washingtonpost.com/health/2026/...
Epic sues health information network over nearly 300,000 illegally accessed records
www.statnews.com/2026/01/13/e...
www.statnews.com/2026/01/13/e...
Epic sues health information network over nearly 300,000 illegally accessed records
Epic Systems is suing Health Gorilla, a health information network, over improperly accessing nearly 300,000 patient records.
www.statnews.com
January 14, 2026 at 1:56 AM
Epic sues health information network over nearly 300,000 illegally accessed records
www.statnews.com/2026/01/13/e...
www.statnews.com/2026/01/13/e...
Rhode Island predicted cancer incidence according to ACS and the R.I. population.
2025
7480 new cases 1,112,308 pop 0.6725%
2021
6910 new cases 1,097,246 pop
0.6298%
2019
6540 new cases 1,058,158 pop
0.6180%
2017
5870 new cases 1,056,554 pop
0.5556%
2025
7480 new cases 1,112,308 pop 0.6725%
2021
6910 new cases 1,097,246 pop
0.6298%
2019
6540 new cases 1,058,158 pop
0.6180%
2017
5870 new cases 1,056,554 pop
0.5556%
January 14, 2026 at 1:29 AM
Rhode Island predicted cancer incidence according to ACS and the R.I. population.
2025
7480 new cases 1,112,308 pop 0.6725%
2021
6910 new cases 1,097,246 pop
0.6298%
2019
6540 new cases 1,058,158 pop
0.6180%
2017
5870 new cases 1,056,554 pop
0.5556%
2025
7480 new cases 1,112,308 pop 0.6725%
2021
6910 new cases 1,097,246 pop
0.6298%
2019
6540 new cases 1,058,158 pop
0.6180%
2017
5870 new cases 1,056,554 pop
0.5556%
Pleased to share PubMed link for the latest publication from #eldeirylab
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
pubmed.ncbi.nlm.nih.gov/41523261/
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
pubmed.ncbi.nlm.nih.gov/41523261/
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma - PubMed
<span><i>ITGB6</i>, the gene encoding the β6 subunit of integrin αvβ6, is a potent prognostic marker across multiple cancer types. As a major activator of latent TGFβ and a potent modulator of the tumor immune environment, αvβ6, and consequently, <i>ITGB6</i>, has considerable therapeutic implications. </span> …
pubmed.ncbi.nlm.nih.gov
January 13, 2026 at 8:25 PM
Pleased to share PubMed link for the latest publication from #eldeirylab
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
pubmed.ncbi.nlm.nih.gov/41523261/
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
pubmed.ncbi.nlm.nih.gov/41523261/
'A bombshell': doubt cast on discovery of
microplastics throughout human body
www.theguardian.com/environment/...
microplastics throughout human body
www.theguardian.com/environment/...
‘A bombshell’: doubt cast on discovery of microplastics throughout human body
Exclusive: Some scientists say many detections are most likely error, with one high-profile study called a ‘joke’
www.theguardian.com
January 13, 2026 at 3:41 PM
'A bombshell': doubt cast on discovery of
microplastics throughout human body
www.theguardian.com/environment/...
microplastics throughout human body
www.theguardian.com/environment/...
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators
Abstract. The tumor suppressor TP53 is the most frequently altered gene in cancer, and the Y220C hotspot, found in 1.8% of TP53-mutant tumors, creates a druggable cavity that destabilizes p53. Rezatap...
aacrjournals.org
January 13, 2026 at 3:20 AM
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
Resistance to rezatapopt: New TP53 mutations identified in cancer patients
www.news-medical.net/news/2026011...
www.news-medical.net/news/2026011...
Resistance to rezatapopt: New TP53 mutations identified in cancer patients
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics.
www.news-medical.net
January 13, 2026 at 3:18 AM
Resistance to rezatapopt: New TP53 mutations identified in cancer patients
www.news-medical.net/news/2026011...
www.news-medical.net/news/2026011...